Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 41-50
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.41
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.41
Table 1 Patients’ baseline characteristics
| Variable | P values |
| Age, yr (± SD) | 62 ± 10 |
| Male gender, n (%) | 537 (75.9) |
| Non-cirrhotic liver, n (%) | 89 (12.6) |
| Child Pugh A/B/C, n (%) | 352 (49.7)/238 (33.6)/118 (16.7) |
| Comorbidities, n (%) | 299 (42.2) |
| Diabetes mellitus, n (%) | 196 (27.7) |
| Ascites, n (%) | 253 (35.7) |
| Mild | 144 (20.3) |
| Moderate-severe | 109 (15.4) |
| Encephalopathy, n (%) | 147 (20.8) |
| Grade I-II | 137 (19.3) |
| Grade III-IV | 10 (1.4) |
| Esophageal varices, n (%) | 394 (56.7) |
| ECOG 0-2/3-4, n (%) | 637 (89.9)/71 (10.1) |
| Median HCC number, (IQR) | 1.0 (1.0-2.0) |
| Largest HCC diameter, mm (IQR) | 53 ± 37 |
| Within Milan, n (%) | 334 (46.9) |
| Bilobar involvement, n (%) | 159 (22.1) |
| Diffuse HCC pattern, n (%) | 28 (3.9) |
| Median AFP, ng/mL (IQR) | 23.0 (5.0-337.0) |
| ≤ 100 ng/mL, n (%) | 476 (66.3) |
| 101-1000 ng/mL, n (%) | 128 (17.7) |
| > 1000 ng/mL, n (%) | 115 (16.0) |
| Tumor vascular invasion, n (%) | 74 (10.4) |
| Extrahepatic disease, n (%) | 48 (6.8) |
- Citation: Piñero F, Pages J, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Ameigeiras B, D’Amico C, Gaite L, Bermúdez C, Cobos M, Rosales C, Romero G, McCormack L, Reggiardo V, Colombato L, Gadano A, Silva M. Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina. World J Hepatol 2018; 10(1): 41-50
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/41.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.41